Modulus Therapeutics
Pre-clinicalModulus Therapeutics develops cell therapies for cancer using engineered immune cells.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $3.5M
About
Modulus Therapeutics develops cell therapies for cancer using engineered immune cells.
Cell & Gene Therapy
Funding History
1Total raised:$3.5M
Seed$3.5MJun 15, 2023